Global PCOS Treatment Market Size, Share and Forecast 2025 | TechSci Research

MARKET INTELLIGENCE . CONSULTINGwww.techsciresearch.com

GLOBAL PCOS TREATMENT MARKET

FORECAST & OPPORTUNITIES

2015 – 2025

2

Scope of ReportProduct of Interest (POI): PCOS Treatment

Review Period

2015 – 2018

Base Year

2019

Estimated Year

2020

Forecast Period

2021 – 2025

Year Range

Polycystic ovary syndrome (PCOS) is a condition that affects a woman's hormone levels. Women with PCOS producehigher-than-normal amounts of male hormones. This hormone imbalance causes them to skip menstrual periods andmakes it harder for them to get pregnant.

Market Segmentation

DRUG

• Ovulation Inducing Agents

• Insulin-Sensitizing Agents

• Oral Contraceptives

• Antiandrogens

• Anti-Depressants

• Insulin-Sensitizing Agents

• Anti-Obesity Drugs

• Others

SURGERY

• Ovarian Wedge Resection

• Cyst Aspiration

• Laparoscopic Ovarian Drilling

DIAGNOSIS

• Pelvic Examination

• Ultrasound

• Blood Tests

END USER

• Hospitals & Clinics

• Ambulatory Surgical

Centers

• Fertility Clinics

REGION

• Asia Pacific

• Europe

• North America

• South America

• Middle East & Africa

3

Table of Contents

S. No. Contents Page No.

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global PCOS Treatment Market

4. Executive Summary

5. Voice of Customer

6. Global PCOS Treatment Market Outlook

6.1. Market Size & Forecast

6.1.1. By Value

6.2. Market Share & Forecast

6.2.1.By Surgery (Ovarian Wedge Resection, Cyst Aspiration, Laparoscopic Ovarian Drilling)

6.2.2.

By Drug (Ovulation Inducing Agents, Insulin-Sensitizing Agents, Oral Contraceptives, Antiandrogens, Anti-Depressants, Insulin-Sensitizing Agents, Anti-Obesity Drugs, Others)

6.2.3. By Diagnosis (Pelvic Examination, Ultrasound, Blood Tests)

6.2.4. By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Fertility Clinics)

6.2.5. By Company (2019)

6.2.6. By Region

6.3. Product Market Map

7. Asia-Pacific PCOS Treatment Market Outlook

4

Table of Contents



7.1.1. By Value


7.2.1. By Surgery

7.2.2. By Drug

7.2.3. By Diagnosis

7.2.4. By End User

7.2.5. By Country

7.3. Asia-Pacific: Country Analysis

7.3.1. China PCOS Treatment Market Outlook

7.3.1.1. Market Size & Forecast

7.3.1.1.1. By Value

7.3.1.2. Market Share & Forecast

7.3.1.2.1. By Surgery

7.3.1.2.2. By Drug

7.3.1.2.3. By Diagnosis

7.3.1.2.4. By End User

7.3.2. India PCOS Treatment Market Outlook


5

Table of Contents


7.3.2.1.1. By Value



7.3.2.2.2. By Drug



7.3.3. Australia PCOS Treatment Market Outlook


7.3.3.1.1. By Value



7.3.3.2.2. By Drug



7.3.4. Japan PCOS Treatment Market Outlook


7.3.4.1.1. By Value


6

Table of Contents



7.3.4.2.2. By Drug



7.3.5. South Korea PCOS Treatment Market Outlook


7.3.5.1.1. By Value



7.3.5.2.2. By Drug



8. Europe PCOS Treatment Market Outlook


8.1.1. By Value


8.2.1. By Surgery

8.2.2. By Drug

7

Table of Contents


8.2.3. By Diagnosis

8.2.4. By End User

8.2.5. By Country

8.3. Europe: Country Analysis

8.3.1. France PCOS Treatment Market Outlook


8.3.1.1.1. By Value



8.3.1.2.2. By Drug



8.3.2. Germany PCOS Treatment Market Outlook


8.3.2.1.1. By Value



8.3.2.2.2. By Drug

8

Table of Contents




8.3.3. United Kingdom PCOS Treatment Market Outlook


8.3.3.1.1. By Value



8.3.3.2.2. By Drug



8.3.4. Italy PCOS Treatment Market Outlook


8.3.4.1.1. By Value



8.3.4.2.2. By Drug



9

Table of Contents


8.3.5. Spain PCOS Treatment Market Outlook


8.3.5.1.1. By Value



8.3.5.2.2. By Drug



9. North America PCOS Treatment Market Outlook


9.1.1. By Value


9.2.1. By Surgery

9.2.2. By Drug

9.2.3. By Diagnosis

9.2.4. By End User

9.2.5. By Country

9.3. North America: Country Analysis

10

Table of Contents


9.3.1. United States PCOS Treatment Market Outlook


9.3.1.1.1. By Value



9.3.1.2.2. By Drug



9.3.2. Mexico PCOS Treatment Market Outlook


9.3.2.1.1. By Value



9.3.2.2.2. By Drug



9.3.3. Canada PCOS Treatment Market Outlook


11

Table of Contents


9.3.3.1.1. By Value



9.3.3.2.2. By Drug



10. South America PCOS Treatment Market Outlook


10.1.1. By Value


10.2.1. By Surgery

10.2.2. By Drug

10.2.3. By Diagnosis

10.2.4. By End User

10.2.5. By Country

10.3. South America: Country Analysis

10.3.1. Brazil PCOS Treatment Market Outlook


12

Table of Contents


10.3.1.1.1 By Value



10.3.1.2.2. By Drug


10.3.1.2.4. By End User

10.3.2. Argentina PCOS Treatment Market Outlook


10.3.2.1.1 By Value



10.3.2.2.2. By Drug


10.3.2.2.4. By End User

10.3.3. Colombia PCOS Treatment Market Outlook


10.3.3.1.1 By Value


13

Table of Contents



10.3.2.2.2. By Drug


10.3.2.2.4. By End User

11. Middle East and Africa PCOS Treatment Market Outlook


11.1.1. By Value


11.2.1. By Surgery

11.2.2. By Drug

11.2.3. By Diagnosis

11.2.4. By End User

11.2.5. By Country

11.3. Middle East & Africa : Country Analysis

11.3.1. South Africa PCOS Treatment Market Outlook


11.3.1.1.1. By Value


14

Table of Contents



11.3.1.2.2. By Drug


11.3.1.2.4. By End User

11.3.2. Saudi Arabia PCOS Treatment Market Outlook


11.3.2.1.1. By Value



11.3.2.2.2. By Drug


11.3.2.2.4. By End User

11.3.3. UAE PCOS Treatment Market Outlook


11.3.3.1.1. By Value



11.3.3.2.2. By Drug

15

Table of Contents



11.3.3.2.4. By End User

12. Market Dynamics

12.1. Drivers

12.2. Challenges

13. Market Trends & Developments

14. Commonly Used PCOS Drugs to control different symptoms

15. Competitive Landscape

15.1. Bristol-Myers Squibb Company

15.2. Bayer AG

15.3. Pfizer, Inc.

15.4. Abbott Laboratories, Inc.

15.5. Merck & Co., Inc.

15.6. Sanofi SA

15.7. AstraZeneca Plc

15.8. Novartis AG

15.9. Teva Pharmaceutical Industries Limited

15.10. Ferring Pharmaceuticals, Inc.

16

Table of Contents


16. Strategic Recommendations

17. About Us & Disclaimer

RESEARCH METHODOLOGY

18

Research Methodology

✓ Identifying Key Opinion

Leaders

✓ Questionnaire Design

✓ In-depth Interviews

Data Collection

Developing List of Respondents

Formulating Questionnaire

Market Profiling

Data Validation

Data Analysis

In-depth secondary research was conducted to

determine top players in the global PCOS treatment market, overall market size and segmental market size.

In order to conduct industry experts’

interviews, TechSci formulated a detailed

discussion guide.

List of industry players and industry

specialists was developed.

TechSci conducted interviews with

industry experts and industry players for data collection and

verification.

Data obtained as a result of primary and secondary research was

validated through rigorous

triangulation.

The data was scrutinized using MS-Excel, statistical

tools and internal proprietary database to obtain qualitative and

quantitative insights about the global PCOS treatment

market.

Data Collection

Data Filter& Analysis

Research &Intelligence

ActionableInsights

BusinessSolution

Primary Research Desk Research Company Analysis

✓ Recent Developments

✓ Market Changing

Aspects/Dynamics

✓ Government Policies

✓ Conclusion

✓ Market Participants

✓ Key Strengths

✓ LinkedIn✓ TechSci Internal

Database

✓ Factiva✓ Hoovers

Paid Sources

✓ Company Websites✓ Company Annual

Reports✓ White Paper Study✓ Financial Reports✓ Investor

Presentations✓ Regulatory Body✓ Associations, etc.

Secondary Research

Primary Research

19


Baseline Methodology

Our dedicated team of industry experts has monitored and analyzed various aspects of the global PCOS treatment market. The team has

analyzed the outlook of various segments of this market, while considering the major influencing factors such as increase in number of PCOS

treatment and growth in healthcare sector, among others. The study includes market forecasting, which would enable our clients to take better

decisions while planning their strategy to achieve sustainability in the global PCOS treatment market.

Methodology Followed for Calculation of Market Size:

• Market Size by Value & Volume: Market size, in terms of value & volume, for the year 2019 was calculated based on information collected

through exhaustive secondary research and primary surveys, with various key opinion leaders/stakeholders, such as healthcare companies,

channel partners, market influencers & end users, industry experts, and other industry participants.

• The team interviewed more than 15 – 20 PCOS treatment companies, 100 – 120 end users, and 15 – 20 industry experts and other value

chain stakeholders in the global PCOS treatment market to obtain the overall market size from 2015 to 2019, which was validated by the

Delphi technique. Taking standard deviation into consideration, the market size was averaged out, to arrive at the market size data during

2015-2019.

20


• Respondents were asked about the current and future market growth rates, market shares by surgery, by drug, by diagnosis, by end user

and by region. Removing the outlier responses, the geometric mean of growth estimates and provider wise revenue shares generated

across various segments were considered, to arrive at the final revenue shares. Revenue shares generated across various segments were

further triangulated from other stakeholders.

Methodology Followed for Calculation of Market Shares:

• Market shares by surgery, by drug, by Diagnosis, by end user and by region were calculated based on the responses received through

primary surveys with industry experts, in which the respondents were asked about the market shares or revenue generated from various

segments of PCOS treatment market. The final shares were calculated by taking the geometric mean of the responses gathered from key

opinion leaders after eliminating the outliers.

Methodology Followed for Forecasting:

• TechSci Research performed periodical checks on data collected through the surveys with logic checks and analyzed the survey results in

SPSS/Tableau Software.

• Data triangulation techniques were applied to fill the gaps and to present a more meaningful picture of the market. To forecast global PCOS

treatment market, TechSci Research used various forecast techniques such as:

✓ Moving Average

✓ Time Series Analysis

✓ Regression Analysis

✓ Econometric and Judgmental Analysis

21


TechSci Research used its own forecast tool, which is based on the growth of various allied industries in respective regions. TechSci Research

also used the impact analysis during short, medium and long term period to estimate the demand and to reach accurate market numbers. It

should be noted that the figures compiled are only for the organized market including market share data. The currency used in the report is the

United States Dollar (USD), with the market size indicated in USD million.

Partial List of Companies Interviewed Key Secondary Sources

▪ Bristol-Myers Squibb Company

▪ Bayer AG

▪ Pfizer, Inc.

▪ Abbott Laboratories, Inc.

▪ Merck & Co., Inc.

▪ Sanofi SA

▪ AstraZeneca Plc

▪ Novartis AG

▪ Teva Pharmaceutical Industries Limited

▪ Ferring Pharmaceuticals, Inc.

▪ World Bank

▪ TechSci Research Proprietary Database & Knowledge

Repository

▪ Company Annual Reports

▪ Industry Magazines

▪ Industry Reports

▪ News Dailies

▪ Credible Paid Databases

22

Industry Brief

According to TechSci Research report, “Global PCOS Treatment Market By Treatment (Surgeries v/s Drug Treatment), By Diagnosis (Pelvic

Examination, Ultrasound, Blood Tests), By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Fertility Clinics), By Region, Forecast &

Opportunities, 2025”, the global PCOS treatment market is expected to grow at a formidable rate during the forecast period on account of the

rising awareness pertaining to diseases and reproductive health among the population. Additionally, initiatives taken by various government and

non-government organizations for spreading awareness and providing schemes and services for the welfare of women is further expected to

positively impact the growth of market over the next few years. Furthermore, easy access to PCOS therapeutics, growing demand for PCOS

medication and rising popularity of combination therapy are further expected to foster the growth of market through 2025. However, easy

availability of generics and off the label drugs might hinder the growth of market during forecast period. Additionally, lack of approved

therapeutics and side effects of the available drugs might hamper the growth of market over the next few years. Also, at present no targeted

therapy is available for this syndrome & it is only controlled through medication and some surgical procedures.

The global PCOS treatment market is segmented based on treatment, diagnosis, end user, company and region. Based on treatment the market

can be bifurcated into surgeries and drug treatment. The drug treatment segment can further be categorized into oral contraceptives,

antiandrogens, anti-depressants, insulin-sensitizing agents, anti-obesity drugs, others. The insulin-sensitizing agents segment is expected to

dominate the market since they lower the insulin levels in blood and help in maintaining hormonal balance. The surgeries segment is further

bifurcated into ovarian wedge resection and laparoscopic ovarian drilling. The ovarian wedge resection segment is expected to witness

significant growth during the forecast years as this method removes some part of the ovary, which helps in regulating menstrual cycle and

promotes ovulation.

Bristol-Myers Squibb Company, Bayer AG, Pfizer, Inc., Abbott Laboratories, Merck & Co., Inc., Sanofi SA, AstraZeneca Plc, Novartis AG, Teva

Pharmaceutical Industries Limited, Ferring Pharmaceuticals, Inc., Neurocrine Biosciences, Inc., EffRx Pharmaceuticals SA, Mylan N.V., Millendo

Therapeutics, Inc. and others are some of the leading players operating in global PCOS treatment market. The companies operating in the

market are using organic strategies such as product launches, mergers and collaborations to boost their share. For instance, in January 2106,

AstraZeneca announced that they have started start up for women health treatment and invested USD62 million in drug development for poly

cystic ovarian disorder.

“North America is expected to dominate the global PCOS treatment market during the forecast period, owing to the presence of well-developed

healthcare infrastructure in the region. Additionally, availability of skilled medical personnel coupled with large PCOS patient pool in the region is

further expected to create lucrative opportunities for the market players over the next few years. Furthermore, better reimbursement policies in

the region are encouraging the population for PCOS treatment and surgeries, thereby anticipated to drive the growth of market over the next few

years.” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.

23

Sample Data - Snapshot

5.00 6.00 7.00 8.00 9.00 10.00 11.00 12.00 13.00 14.00 15.00

2015 2019 2020E 2025F

Global PCOS Treatment Market Size, By Value (USD Million), 2015–2025F

CAGR By Value

XX%CAGR By Value

YY%

North America PCOS Treatment Market Share, By Surgery, By Value, 2015–2025F

30%30%30%30%30%30%30%30%30%30%30%

40%40%40%40%40%40%40%40%40%40%40%

30%30%30%30%30%30%30%30%30%30%30%

2015

2016

2017

2018

2019

2020E

2021F

2022F

2023F

2024F

2025F

Ovarian Wedge Resection Cyst Aspiration Laparoscopic Ovarian Drilling

United State PCOS Treatment Market Share, By Drug, By Value, 2015–2025F

20%20%

20%

20%

20%

20%

20%

20%

20%

20%

20%

10%10%

10%

10%

10%

10%

10%

10%

10%

10%

10%

20%20%

20%

20%

20%

20%

20%

20%

20%

20%

20%

10%10%

10%

10%

10%

10%

10%

10%

10%

10%

10%

10%10%

10%

10%

10%

10%

10%

10%

10%

10%

10%

10%10%

10%

10%

10%

10%

10%

10%

10%

10%

10%

20%20%

20%

20%

20%

20%

20%

20%

20%

20%

20%

2015

2016

2017

2018

2019

2020E

2021F

2022F

2023F

2024F

2025F

Ovulation Inducing Agents Insulin-Sensitizing Agents Oral Contraceptives Antiandrogens

Anti-Depressants Anti-Obesity Drugs Others

24

Report Ordering

Report Name: GLOBAL PCOS TREATMENT MARKET

FORECAST & OPPORTUNITIES

2015 – 2025

To View Sample OR Purchase Report

License Type Price

Single User License $4450

Multi-User License $5450

Custom Research License $9450

https://www.techsciresearch.com/report/pcos-treatment-market/4683.html

About Us & Disclaimer

TechSci Research is a global market research and consulting company with offices in the US, UK and India. TechSci Research provides market research reports in

number of areas to organizations. The company uses innovative business models that focus on improving productivity, while ensuring creation of high-quality reports. The

proprietary forecasting models use various analyses of both industry-specific and macroeconomic variables on a state-by-state basis to produce a unique ‘bottom-up’

model of a country, regional and global industry prospects. Combined with the detailed analysis of company activity and industry trends, the result is a uniquely rich

evaluation of the opportunities available in the market.

Related Reports

• Global Spinal Cord Stimulation Devices Market By Product Type (Rechargeable v/s Non-Rechargeable) By Application (Failed Back

Syndrome, Complex Regional Pain Syndrome, Degenerative Disk Disease, Unsuccessful Disk Surgery, Others) By End User (Hospitals &

Clinics, Ambulatory Care Centers, Others) By Region, Competition Forecast & Opportunities, 2026.

• ◾Global Topical Drug Delivery Market By Product (Semi-Solid Formulations, Liquid Formulations, Solid Formulations, Transdermal

Products) By Route of Administration (Dermal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery, Vaginal Drug Delivery,

Nasal Drug Delivery) By End-User (Hospitals, Clinics, Home Healthcare, Diagnostic Centers, Others) By Distribution Channel (Online vs.

Offline) By Region, Competition Forecast & Opportunities, 2026

The contents of this report are based on information generally available to the public from sources believed to be reliable. No representation is made that it is timely,accurate or complete. TechSci Research has taken due care and caution in compilation of data as this has been obtained from various sources including which it considersreliable and firsthand. However, TechSci Research does not guarantee the accuracy, adequacy or completeness of any information and it is not responsible for any errors oromissions or for the results obtained from the use of such information and especially states that it has no financial liability whatsoever to the subscribers / users of thisreport. The information herein, together with all estimates and forecasts, can change without notice. All the figures provided in this document are indicative of relative marketsize and are strictly for client’s internal consumption. Usage of the same for purpose other than internal will require prior approval of TechSci Research.

TechSci Research – North America708 Third Avenue, Manhattan,

New York, United StatesTel: +1- 646- 360- 1656

Email: [email protected] www.techsciresearch.com

Disclaimer

TechSci Research – Europe54, Old brook, Bretton,

Peterborough, United Kingdom


TechSci Research – Asia-PacificB – 44, Sector – 57, Noida, National Capital

Region, U.P. - IndiaTel: +91-120-4523900


Global PCOS Treatment Market Size, Share and Forecast 2025 | TechSci Research

Health & Medicine

Transcript of Global PCOS Treatment Market Size, Share and Forecast 2025 | TechSci Research